GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » Net Interest Income (for Banks)

Gentian Diagnostics AS (OSL:GENT) Net Interest Income (for Banks)


View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Gentian Diagnostics AS Business Description

Traded in Other Exchanges
N/A
Address
Bjornasveien 5, Moss, NOR, 1596
Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.